ImmunoPrecise Presents Novel T-Cell Engaging Bispecific Antibodies Addressing a Unique Oncological…
Immunoprecise Antibodies Ltd, an AI-driven biotherapeutic research and technology company, is pleased to announce that its wholly owned subsidiary,…